These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23231961)

  • 1. Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease.
    van Koppen A; Joles JA; Bongartz LG; van den Brandt J; Reichardt HM; Goldschmeding R; Nguyen TQ; Verhaar MC
    Cell Transplant; 2012; 21(10):2299-312. PubMed ID: 23231961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease.
    van Koppen A; Papazova DA; Oosterhuis NR; Gremmels H; Giles RH; Fledderus JO; Joles JA; Verhaar MC
    Stem Cell Res Ther; 2015 Apr; 6(1):63. PubMed ID: 25889756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5/6th nephrectomy in combination with high salt diet and nitric oxide synthase inhibition to induce chronic kidney disease in the Lewis rat.
    van Koppen A; Verhaar MC; Bongartz LG; Joles JA
    J Vis Exp; 2013 Jul; (77):e50398. PubMed ID: 23851420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease.
    van Koppen A; Joles JA; van Balkom BW; Lim SK; de Kleijn D; Giles RH; Verhaar MC
    PLoS One; 2012; 7(6):e38746. PubMed ID: 22723882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure.
    Caldas HC; Fernandes IM; Gerbi F; Souza AC; Baptista MA; Ramalho HJ; Kawasaki-Oyama RS; Goloni-Bertollo EM; Pavarino-Bertelli EC; Braile DM; Abbud-Filho M
    Transplant Proc; 2008 Apr; 40(3):853-5. PubMed ID: 18455035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autologous bone marrow cell infusion therapy for liver cirrhosis--now and future].
    Sakaida I
    Rinsho Byori; 2011 Dec; 59(12):1092-8. PubMed ID: 22338911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.
    Steiner RW; Tucker BJ; Blantz RC
    J Clin Invest; 1979 Aug; 64(2):503-12. PubMed ID: 457865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis.
    Uchimura H; Marumo T; Takase O; Kawachi H; Shimizu F; Hayashi M; Saruta T; Hishikawa K; Fujita T
    J Am Soc Nephrol; 2005 Apr; 16(4):997-1004. PubMed ID: 15744001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.
    Picken M; Long J; Williamson GA; Polichnowski AJ
    Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of probucol in renal function and structure in rats with subtotal kidney ablation.
    Modi KS; Schreiner GF; Purkerson ML; Klahr S
    J Lab Clin Med; 1992 Aug; 120(2):310-7. PubMed ID: 1500828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat.
    Eyre HJ; Speight T; Glazier JD; Smith DM; Ashton N
    Exp Physiol; 2019 Mar; 104(3):421-433. PubMed ID: 30575177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow progression of chronic kidney disease and what it is associated with.
    Eftimovska N; Stojceva-Taneva O; Polenakovic M
    Prilozi; 2008 Jul; 29(1):153-65. PubMed ID: 18709007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of protease therapy in the remnant kidney model of progressive renal failure.
    Sebekova K; Paczek L; Dämmrich J; Ling H; Spustova V; Gaciong Z; Heidland A
    Miner Electrolyte Metab; 1997; 23(3-6):291-5. PubMed ID: 9387136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of renal sympathetic nerve overactivation in the progression of chronic kidney disease in rats.
    Kobuchi S; Tanaka R; Funai A; Suzuki R; Yazawa M; Tsutsui H; Ohkita M; Ayajiki K; Matsumura Y
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):9-15. PubMed ID: 24084211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease.
    Bongartz LG; Braam B; Verhaar MC; Cramer MJ; Goldschmeding R; Gaillard CA; Doevendans PA; Joles JA
    Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R815-23. PubMed ID: 20032261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal vascular structural properties and their alterations by removal of uraemic toxins in a rat model of chronic kidney disease.
    Yamazaki H; Tomoda F; Koike T; Kinuno H; Sugimori H; Inoue H; Bannai K; Sugano M; Nishijima F
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):238-45. PubMed ID: 24471839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
    Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.